KRAS and pancreatitis: For example, a recent study [58] has shown that pancreatitis‐mediated epigenetic remodeling promotes the selection of oncogenic KRAS mutations, leading to reduced tissue damage in future bouts of pancreatitis, while at the same time increasing the risks of pancreatic cancer (which in humans mostly occurs in old age).